The rising incidence of cancer worldwide has led to an increasing number of surgeries that involve the removal of lymph nodes ...
At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...
Businessman, influencer, and public speaker Brian Mazza was diagnosed with male factor infertility. Tests showed he had a low sperm count, and he felt as if he was letting down his wife and family. He ...
Dear Dr. Roach: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low blood platelet count, I ...
At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether routine blood-based immune markers could help predict response to neoadjuvant ...
Objectives This study aimed to examine the association between the neutrophil-to-lymphocyte ratio (NLR) and the prognosis of patients with breast cancer (BC) in southern Ethiopia. Design We conducted ...
Lymphedema after head and neck cancer is considerably more common than previously assumed and can persist long after cancer treatment has finished. Researchers at Lund University in Sweden have ...
PACIFIC GROVE — The Thanksgiving holiday has historically marked the peak sightings of western monarch butterflies on California’s Central Coast. The peak reached 8,000 this year, a fraction of what ...
The monarch butterfly migration is off to a tough start this season — with fewer butterflies than usual fluttering to the Pismo State Beach Monarch Butterfly Grove. As of Wednesday, California State ...
To investigate this further, first author, Gabriella N. Tortorello, MD, and a research team from the University of Pennsylvania, performed a retrospective cohort study with data from the National ...
Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to ...